What The Study Did:
This study examined how common and at what cost is the practice of so-called “clawbacks” for topical prescription drugs when an insured patient’s copayment exceeds the insurer’s cost for the drug.
To access the embargoed study:
Visit our For The Media website at this link
https:/
/
media.
jamanetwork.
com/
Authors:
Joslyn Kirby, M.D., M.S., M.Ed., of the Penn State Milton S. Hershey Medical Center in Hershey, Pennsylvania, is the corresponding author.
(doi:10.1001/jamadermatol.2019.3078)
Editor’s Note:
Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
###
Media advisory:
The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article
This link will be live at the embargo time
https:/
/
jamanetwork.
com/
journals/
jamadermatology/
fullarticle/
10.
1001/
jamadermatol.
2019.
3078?guestAccessKey=
c5c178d0-6aee-4ff5-9256-81da7592f27a&utm_source=
For_The_Media&utm_medium=
referral&utm_campaign=
ftm_links&utm_content=
tfl&utm_term=
100919
This part of information is sourced from https://www.eurekalert.org/pub_releases/2019-10/jn-sac100719.php
JAMA Network Media Relations
[email protected]
https://media.jamanetwork.com/